Alto Neuroscience promotes Nick Smith to president and CFO

Alto Neuroscience, Inc. (NYSE: ANRO) has promoted Nick Smith to president and chief financial officer, effective August 26, 2026, according to a company statement.

Smith will continue to oversee Alto's finance function while also leading corporate strategy and business development. He will report to Amit Etkin, M.D., Ph.D., the company's founder, chief executive officer, and chair of the board of directors.

Smith joined Alto in 2021 as chief business officer and has served as chief financial officer since 2022. During that period, he led the company's initial public offering, the acquisition of ALTO-207 in May 2025, and subsequent financings related to that program's development.

"Nick has been an exceptional partner in building Alto and has played a central role in the strategic and financial actions that have positioned the company for its next stage," Etkin said. "This promotion recognizes the breadth of his leadership and formalizes the role he already plays as we advance ALTO-207 and the broader pipeline."

You May Also Be Interested In

• Outlook Therapeutics names Kevin Lundquist as CFO ahead of U.S. launch
• WestPark Capital completes $940M Advasa direct listing on Nasdaq
• argenx completes $77-per-share acquisition of Forte Biosciences